In Brief: Rogaine sales
This article was originally published in The Tan Sheet
Executive Summary
Rogaine sales: Rx and OTC sales of the baldness treatment reach $189 mil. worldwide in 1996, of which $162.3 mil. was in the U.S. Pharmacia & Upjohn previously said that U.S. Rogaine 1996 sales were $189 mil. ("The Tan Sheet" March 3, p. 14)...
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning